Federated Hermes, Inc. Champions Oncology, Inc. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.76 - $10.23 $45,737 - $60,295	-5,894 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.11 - $10.96 $53,694 - $64,598	5,894 New	5,894 $59,000
Q1 2019 May 10, 2019	SELL	$7.89 - $12.23 $5,183 - $8,035	-657 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$7.29 - $15.27 $1,144 - $2,397	157 Added 31.4%	657 $5,000
Q3 2018 Nov 13, 2018	BUY	$5.82 - $17.47 $2,910 - $8,735	500 New	500 $9,000

5.82M

15K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $107M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.